During a national shortage, every vial of medication matters. That is especially true for Hikma dantrolene, the only treatment for Malignant Hyperthermia, a rare but potentially fatal reaction to certain anesthetics.

When a hospital accidentally ordered 72 boxes instead of 72 vials, receiving 432 vials in total, the country’s remaining supply was unintentionally depleted. With allocation controls not yet in place and returns not possible, the situation created real risk for hospitals across Canada that rely on dantrolene for emergency response kits and urgent patient care.

That is when Tammy Valliere, Specialist in Pharmacy Member Success at HealthPRO Canada, acted quickly.

Recognizing the urgency, Tammy activated HealthPRO Canada’s Drug Shortage Network, leveraging HealthPRO Canada’s unique role as a common link between hospitals and suppliers nationwide. That visibility made it possible to identify where supply existed, where it was urgently needed, and how to move it safely and efficiently.

Tammy led the redistribution of excess dantrolene to hospitals in multiple provinces, including sites in immediate need to support patients and maintain critical emergency kits. Life-saving medication was moved from where it could not be used in time to where it was essential, ensuring no doses were wasted.

The effort required rapid decision-making, cross-provincial coordination, and close collaboration with members and healthcare partners. Tammy quarterbacked every step, keeping the focus on one outcome: ensuring patients across Canada would have access to this critical medication when it mattered most.

This moment reflects the power of scale, connection, and decisive action. By serving as the common link between hospitals and suppliers nationwide, HealthPRO Canada can advocate, coordinate, and respond quickly when it matters most. Through the leadership of professionals like Tammy, that system-level visibility translates into safer care for patients, when every dose truly matters.